BACKGROUND: Apolipoprotein E (apoE) and cholesterol play a critical role in synapse and myelin maintenance and integrity and are thus appealing candidates in the pathogenesis of schizophrenia and bipolar disorder. To explore the role of these 2 molecules, we quantified cholesterol and apoE levels in prefrontal grey and white matter in patients with schizophrenia, bipolar disorder and healthy controls. Furthermore, we investigated the relations between apoE and cholesterol levels and the APOE genotype. METHODS: We obtained dorsolateral prefrontal grey and white matter from the Stanley Medical Research Institute Brain Collection (schizophrenia n = 35, bipolar disorder n = 35 and controls n = 35). Cholesterol levels were quantified using high-pressure liquid chromatography, whereas apoE was measured by enzyme-linked immunosorbent assay. RESULTS: We found no significant differences in cholesterol or apoE levels among the groups. ApoE levels were higher in grey matter than in white matter in all groups; conversely, levels of cholesterol were higher in white matter than in grey matter. We observed a significant inverse correlation between apoE and cholesterol levels in both grey and white matter. Furthermore, in grey matter, apoE levels were significantly higher in APOE ε2 carriers compared with APOE ε3 or APOE ε4 carriers, with cholesterol levels following the opposite trend. LIMITATIONS: LIMITATIONS of our study include our inability to control for potential confounding variables and the small numbers of APOE ε2 and ε4 carriers in each group. CONCLUSION: Although large amounts of cholesterol are present in white matter, apoE expression is limited. The APOE genotype may play a role in the regulation of both cholesterol and apoE levels in grey matter. The impact of APOE polymorphisms on lipid homeostasis in people with psychiatric disorders warrants further investigation.
BACKGROUND:Apolipoprotein E (apoE) and cholesterol play a critical role in synapse and myelin maintenance and integrity and are thus appealing candidates in the pathogenesis of schizophrenia and bipolar disorder. To explore the role of these 2 molecules, we quantified cholesterol and apoE levels in prefrontal grey and white matter in patients with schizophrenia, bipolar disorder and healthy controls. Furthermore, we investigated the relations between apoE and cholesterol levels and the APOE genotype. METHODS: We obtained dorsolateral prefrontal grey and white matter from the Stanley Medical Research Institute Brain Collection (schizophrenia n = 35, bipolar disorder n = 35 and controls n = 35). Cholesterol levels were quantified using high-pressure liquid chromatography, whereas apoE was measured by enzyme-linked immunosorbent assay. RESULTS: We found no significant differences in cholesterol or apoE levels among the groups. ApoE levels were higher in grey matter than in white matter in all groups; conversely, levels of cholesterol were higher in white matter than in grey matter. We observed a significant inverse correlation between apoE and cholesterol levels in both grey and white matter. Furthermore, in grey matter, apoE levels were significantly higher in APOE ε2 carriers compared with APOE ε3 or APOE ε4 carriers, with cholesterol levels following the opposite trend. LIMITATIONS: LIMITATIONS of our study include our inability to control for potential confounding variables and the small numbers of APOE ε2 and ε4 carriers in each group. CONCLUSION: Although large amounts of cholesterol are present in white matter, apoE expression is limited. The APOE genotype may play a role in the regulation of both cholesterol and apoE levels in grey matter. The impact of APOE polymorphisms on lipid homeostasis in people with psychiatric disorders warrants further investigation.
Authors: Nicole C Allen; Sachin Bagade; Matthew B McQueen; John P A Ioannidis; Fotini K Kavvoura; Muin J Khoury; Rudolph E Tanzi; Lars Bertram Journal: Nat Genet Date: 2008-07 Impact factor: 38.330
Authors: J A Morrow; M L Segall; S Lund-Katz; M C Phillips; M Knapp; B Rupp; K H Weisgraber Journal: Biochemistry Date: 2000-09-26 Impact factor: 3.162
Authors: Vilte E Barakauskas; Clare L Beasley; Alasdair M Barr; Athena R Ypsilanti; Hong-Ying Li; Allen E Thornton; Hubert Wong; Gorazd Rosokilja; J John Mann; Branislav Mancevski; Zlatko Jakovski; Natasha Davceva; Boro Ilievski; Andrew J Dwork; Peter Falkai; William G Honer Journal: Neuropsychopharmacology Date: 2010-01-13 Impact factor: 7.853
Authors: J T-J Huang; L Wang; S Prabakaran; M Wengenroth; H E Lockstone; D Koethe; C W Gerth; S Gross; D Schreiber; K Lilley; M Wayland; D Oxley; F M Leweke; S Bahn Journal: Mol Psychiatry Date: 2007-10-16 Impact factor: 15.992
Authors: David R Riddell; Hua Zhou; Kevin Atchison; Helen K Warwick; Peter J Atkinson; Julius Jefferson; Lin Xu; Suzan Aschmies; Yolanda Kirksey; Yun Hu; Erik Wagner; Adrienne Parratt; Jane Xu; Zhuting Li; Margaret M Zaleska; J Steve Jacobsen; Menelas N Pangalos; Peter H Reinhart Journal: J Neurosci Date: 2008-11-05 Impact factor: 6.167
Authors: Khaled Al Awam; Ida Sibylle Haußleiter; Ed Dudley; Rossen Donev; Martin Brüne; Georg Juckel; Johannes Thome Journal: J Neural Transm (Vienna) Date: 2014-05-01 Impact factor: 3.575
Authors: Alisa G Woods; Izabela Sokolowska; Regina Taurines; Manfred Gerlach; Edward Dudley; Johannes Thome; Costel C Darie Journal: J Cell Mol Med Date: 2012-06 Impact factor: 5.310
Authors: José J Martínez-Magaña; Alma D Genis-Mendoza; Carlos A Tovilla-Zarate; Thelma B González-Castro; Isela Esther Juárez-Rojop; Yazmín Hernández-Díaz; Angélica G Martinez-Hernandez; Humberto Garcia-Ortíz; Lorena Orozco; María L López-Narvaez; Humberto Nicolini Journal: Mol Genet Genomic Med Date: 2019-09-26 Impact factor: 2.183
Authors: Christian Knöchel; Jonathan Kniep; Jason D Cooper; Michael Stäblein; Sofia Wenzler; Jan Sarlon; David Prvulovic; David E J Linden; Sabine Bahn; Pawel Stocki; Sureyya Ozcan; Gilberto Alves; Andre F Carvalho; Andreas Reif; Viola Oertel-Knöchel Journal: Eur Arch Psychiatry Clin Neurosci Date: 2016-08-22 Impact factor: 5.270
Authors: Robinson Ramírez-Vélez; Nicolás Martínez-Velilla; María Correa-Rodríguez; Mikel L Sáez de Asteasu; Fabricio Zambom-Ferraresi; Sara Palomino-Echeverria; Antonio García-Hermoso; Mikel Izquierdo Journal: Geroscience Date: 2022-02-04 Impact factor: 7.581